---
figid: PMC3023199__zh10011161380003
figtitle: PPARG ligand treatments increase expression of mitochondria-associated metabolic
  pathways in adipose tissue
organisms:
- Rattus norvegicus
- Homo sapiens
organisms_ner:
- Homo sapiens
- Rattus norvegicus
- Drosophila melanogaster
pmcid: PMC3023199
filename: zh10011161380003.jpg
figlink: /pmc/articles/PMC3023199/figure/F3/
number: F3
caption: 'PPARγ ligand treatments increase expression of mitochondria-associated metabolic
  pathways in adipose tissue. Selected genes upregulated in ligand-treated adipose
  tissue are shown for the oxidative phosphorylation (A) and TCA cycle and BCAA degradation
  metabolic pathways (B). Red ovals, genes upregulated in PPARγ ligand-treated vs.
  FC groups. Unfilled ovals, no gene expression difference comparing ligand-treated
  and FC groups. Yellow-outlined ovals, genes exhibiting ligand-selective expression
  patterns (ANOVA, P < 0.05). Figures adapted from KEGG. C: examples of BCAA degradation
  pathway genes exhibiting ligand-selective expression that perfectly correlates with
  ligand treatment potency (Spearman, ρ = 1). Data are averages normalized to LC group
  ± SE. ANOVA P < 0.05 for each. *αbonf < 0.05 vs. FC group.'
papertitle: Multi-tissue, selective PPARγ modulation of insulin sensitivity and metabolic
  pathways in obese rats.
reftext: Gene Hsiao, et al. Am J Physiol Endocrinol Metab. 2011 Jan;300(1):E164-E174.
year: '2011'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.7301278
figid_alias: PMC3023199__F3
figtype: Figure
redirect_from: /figures/PMC3023199__F3
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3023199__zh10011161380003.html
  '@type': Dataset
  description: 'PPARγ ligand treatments increase expression of mitochondria-associated
    metabolic pathways in adipose tissue. Selected genes upregulated in ligand-treated
    adipose tissue are shown for the oxidative phosphorylation (A) and TCA cycle and
    BCAA degradation metabolic pathways (B). Red ovals, genes upregulated in PPARγ
    ligand-treated vs. FC groups. Unfilled ovals, no gene expression difference comparing
    ligand-treated and FC groups. Yellow-outlined ovals, genes exhibiting ligand-selective
    expression patterns (ANOVA, P < 0.05). Figures adapted from KEGG. C: examples
    of BCAA degradation pathway genes exhibiting ligand-selective expression that
    perfectly correlates with ligand treatment potency (Spearman, ρ = 1). Data are
    averages normalized to LC group ± SE. ANOVA P < 0.05 for each. *αbonf < 0.05 vs.
    FC group.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ATP8A2
  - NT5E
  - PNPLA6
  - FURIN
  - NEDD9
  - BCAR1
  - CACNA1G-AS1
  - EHHADH
  - BCAT2
  - SERPINA3
  - ACTG1
  - ACTG2
  - FHL5
  - ACOT7
  - ACTBL2
  - POTEKP
  - POTEM
  - TRE-TTC3-1
  - TREH
  - PCCA
  - ALDH2
  - TRO
  - Furin
  - Cat
  - Ccne1
  - Ehhadh
  - Bcat2
  - Pcca
  - Aldh2
  - Aldh1a1
  - Tro
  - ATPsynbeta
  - Atpalpha
  - Me
  - Ne
  - ATPsynCF6L
  - ATPsynCF6
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - CycE
  - cyc
  - act
  - Act5C
  - .na.character
  - Act42A
  - Actbeta
  - ra
  - pie
  - ag
  - tre
  - Gr5a
  - Treh
  - Tre1
  - fc
  - Sh
  - Coa
  - vs
---
